PRU
31
-16
FSLR
32
-11
RCL
47
-7
AMT
52
-6
KSS
15
2
FITB
43
-6
OMC
39
-5
AVY
46
-2
ECL
29
-11
TRIP
16
-13
SYK
26
-11
EBAY
33
-9
TGT
33
-2
SNA
33
-9
CMI
36
-6
BK
43
-15
ORLY
50
-16
HON
39
-13
MAT
30
-4
FDX
19
-15
PRU
31
-16
FSLR
32
-11
RCL
47
-7
AMT
52
-6
KSS
15
2
FITB
43
-6
OMC
39
-5
AVY
46
-2
ECL
29
-11
TRIP
16
-13
SYK
26
-11
EBAY
33
-9
TGT
33
-2
SNA
33
-9
CMI
36
-6
BK
43
-15
ORLY
50
-16
HON
39
-13
MAT
30
-4
FDX
19
-15
Financhill
Back

Barclays PLC Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
38

BCLYF
Barclays PLC

Last Price:
$3.28
Seasonality Move:
1.19%
Sell
46

SRPT
Sarepta Therapeutics

Last Price:
$54.38
Seasonality Move:
15.14%
Sell
38
Barclays PLC (BCLYF) is a Sell

Is Barclays PLC a Buy, Sell or Hold?

  • The current Barclays PLC [BCLYF] share price is $3.28. The Score for BCLYF is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • BCLYF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $54.43. The Score for SRPT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BCLYF Stock Price Chart

What is Barclays PLC's stock price today?

  • The Barclays PLC share price today is $3.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLYF is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $54.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

BCLYF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 36.34 Sell
Chaikin Money Flow: 5955 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.63 - 4.01) Sell
Bollinger Bands (100): (3.27 - 3.81) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -11.96 Sell
Relative Strength Index (14 RSI): 19.8 Sell
Chaikin Money Flow: -4277485 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.24 - 101.14) Sell
Bollinger Bands (100): (90.97 - 127.95) Sell

BCLYF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.76 Sell
20-day SMA: 3.79 Sell
50-day SMA: 3.77 Sell
200-day SMA: 3.21 Buy
8-day EMA: 3.68 Sell
20-day EMA: 3.77 Sell
50-day EMA: 3.72 Sell
200-day EMA: 3.25 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.54 Sell
20-day SMA: 78.39 Sell
50-day SMA: 97.73 Sell
200-day SMA: 122.38 Sell
8-day EMA: 63.87 Sell
20-day EMA: 75.73 Sell
50-day EMA: 92.2 Sell
200-day EMA: 113.44 Sell

Barclays PLC Earnings Growth & BCLYF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.39 per share, a decrease next quarter of $0.51 per share, an increase this year of $5.17 per share, and an increase next year of $5.45 per share.

Barclays PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):